IMMUNOHISTOCHEMICAL ANALYSIS OF THE P53 ONCOPROTEIN ON PARAFFIN SECTIONS USING A SERIES OF NOVEL MONOCLONAL-ANTIBODIES

被引:116
作者
BARTEK, J [1 ]
BARTKOVA, J [1 ]
LUKAS, J [1 ]
STASKOVA, Z [1 ]
VOJTESEK, B [1 ]
LANE, DP [1 ]
机构
[1] UNIV DUNDEE, DEPT BIOCHEM, CANC RES CAMPAIGN LABS, DUNDEE DD1 4HN, SCOTLAND
关键词
P53; ONCOPROTEIN; MONOCLONAL ANTIBODIES; IMMUNOHISTOCHEMISTRY; TUMOR SUPPRESSOR GENES;
D O I
10.1002/path.1711690106
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Alterations of the p53 tumour suppressor gene are considered critical events in multistage carcinogenesis of a wide range of human cancers. In an attempt to elucidate the role of various p53 mutations in tumorigenesis and to investigate their relationship to the p53 protein accumulation and subcellular localization, we have raised a new series of 21 mouse monoclonal antibodies (MAbs) to human recombinant p53. The new MAbs (designated the Bp53 series) appear to recognize mainly denaturation-resistant epitopes in immunoblotting and the majority of them are suitable for immunostaining of p53 in cultured cells and frozen sections. Furthermore, at least three MAbs (Bp53-11, Bp53-12, and Bp53-28)proved to be reliable reagents for immunohistochemistry on paraffin-embedded specimens. The immunohistochemical analysis of paraffin sections from 118 human tumours of various histogeneses with Bp53-11 and Bp53-12 showed nuclear accumulation of the p53 protein in variable proportion of tumour cells in 76 cases (64 per cent). The influence of three parameters of tissue processing (type of fixative, period of fixation, and duration of autolysis) on p53 protein detection was also investigated. The results of this study provide the necessary basis for wider application of these novel MAbs as tools in both routine histopathology and functional analyses of the p53 oncoprotein.
引用
收藏
页码:27 / 34
页数:8
相关论文
共 30 条
  • [1] ISOLATION OF HUMAN-P53-SPECIFIC MONOCLONAL-ANTIBODIES AND THEIR USE IN THE STUDIES OF HUMAN P53 EXPRESSION
    BANKS, L
    MATLASHEWSKI, G
    CRAWFORD, L
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 159 (03): : 529 - 534
  • [2] SELECTIVE IMMORTALIZATION OF A PHENOTYPICALLY DISTINCT EPITHELIAL-CELL TYPE BY MICROINJECTION OF SV40 DNA INTO CULTURED HUMAN-MILK CELLS
    BARTEK, J
    BARTKOVA, J
    LALANI, EN
    BREZINA, V
    TAYLORPAPADIMITRIOU, J
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1990, 45 (06) : 1105 - 1112
  • [3] BARTEK J, 1991, ONCOGENE, V6, P1699
  • [4] BARTEK J, 1990, ONCOGENE, V5, P893
  • [5] BARTEK J, 1985, J CELL SCI, V75, P17
  • [6] PATTERNS OF EXPRESSION OF THE P53 TUMOR SUPPRESSOR IN HUMAN BREAST TISSUES AND TUMORS INSITU AND INVITRO
    BARTEK, J
    BARTKOVA, J
    VOJTESEK, B
    STASKOVA, Z
    REJTHAR, A
    KOVARIK, J
    LANE, DP
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1990, 46 (05) : 839 - 844
  • [7] P53 PROTEIN ALTERATIONS IN HUMAN TESTICULAR CANCER INCLUDING PREINVASIVE INTRATUBULAR GERM-CELL NEOPLASIA
    BARTKOVA, J
    BARTEK, J
    LUKAS, J
    VOJTESEK, B
    STASKOVA, Z
    REJTHAR, A
    KOVARIK, J
    MIDGLEY, CA
    LANE, DP
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1991, 49 (02) : 196 - 202
  • [8] BENNETT WP, 1991, ONCOGENE, V6, P1779
  • [9] MOLECULAR THEMES IN ONCOGENESIS
    BISHOP, JM
    [J]. CELL, 1991, 64 (02) : 235 - 248
  • [10] CASEY G, 1991, ONCOGENE, V6, P1791